| Fri, Dec 4, 2009 | | | Our Final Offer (Maybe)! That's a FACT! at Motley Fool (Fri, Dec 4)
| | | Wall Street Breakfast: Must-Know News at Seeking Alpha (Fri, Dec 4)
| | | Deals of the day -- mergers and acquisitions at Reuters (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | | Facet Biotech Advises Stockholders to Take No Action in Response to Revised Biogen Idec Tender Offer Marketwire (Thu, Dec 3)
| | | UPDATE - Biogen ups offer for Facet Biotech to $17.50/share at Reuters (Thu, Dec 3)
| | | Biogen raises Facet offer to $17.50 per share AP (Thu, Dec 3)
| | | Biogen Idec Increases Offer to Acquire Facet Biotech to $17.50 Per Share in Cash; Sends Letter to Facet Biotech Stockholders Describing Its Best-and-Final Offer Business Wire (Thu, Dec 3)
| | | Prospecting for Winning Biotechs: Gilead Sciences at Motley Fool (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | | MS drugs scheme fails to deliver results at FT.com (Wed, Dec 2)
| | | Tired of Waiting, Teva Advances at Motley Fool (Wed, Dec 2)
| | | Orphan Drug Status for BioMarin Drug Zacks.com (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | | December's Defensive Game Plan for Biotech at Seeking Alpha (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | | Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz at TheStreet.com (Mon, Nov 30)
| | | UPDATE - FDA holds up Merck KGaA's multiple sclerosis pill at Reuters (Mon, Nov 30)
| | Fri, Nov 27, 2009 | | | Biotech Bargains for Your Portfolio at Motley Fool (Fri, Nov 27)
| | Thu, Nov 26, 2009 | | | Financing Drug Discovery: Recent Deals at Seeking Alpha (Thu, Nov 26)
| | Wed, Nov 25, 2009 | | | Cancer drug preserves insulin cells in diabetes at Reuters (Wed, Nov 25)
| | | Still Enjoying Those Acquisitions, Pfizer? at Motley Fool (Wed, Nov 25)
| | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. GlobeNewswire (Wed, Nov 25)
| | Mon, Nov 23, 2009 | | | [$$] Fitz Bits: Wait for a Retest in Ford at RealMoney by TheStreet.com (Mon, Nov 23)
| Add BIIB News to My Yahoo!:

| |
|